Patents by Inventor Carl Elkin
Carl Elkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230119612Abstract: Provided herein are peptidomimetic macrocycles containing amino acid sequences with at least two modified amino acids that form an intramolecular cross-link that can help to stabilize a secondary structure of the amino acid sequence. Suitable sequences for stabilization include those with homology to the p53 protein. These sequences can bind to the MDM2 and/or MDMX proteins. Also provided herein are methods of using such macrocycles for the treatment of diseases and disorders, such as cancers or other disorders characterized by a low level or low activity of a p53 protein or high level of activity of a MDM2 and/or MDMX protein.Type: ApplicationFiled: June 22, 2022Publication date: April 20, 2023Inventors: Vincent GUERLAVAIS, Carl ELKIN, Huw M. NASH, Tomi K. SAWYER, Bradford J. GRAVES, Eric FEYFANT
-
Publication number: 20220000968Abstract: Provided herein are peptidomimetic macrocycles containing amino acid sequences with at least two modified amino acids that form an intramolecular cross-link that can help to stabilize a secondary structure of the amino acid sequence. Suitable sequences for stabilization include those with homology to the p53 protein. These sequences can bind to the MDM2 and/or MDMX proteins. Also provided herein are methods of using such macrocycles for the treatment of diseases and disorders, such as cancers or other disorders characterized by a low level or low activity of a p53 protein or high level of activity of a MDM2 and/or MDMX protein.Type: ApplicationFiled: January 22, 2021Publication date: January 6, 2022Inventors: Vincent GUERLAVAIS, Carl ELKIN, Huw M. NASH, Tomi K. SAWYER, Bradford J. GRAVES, Eric FEYFANT
-
Patent number: 10967042Abstract: Provided herein are peptidomimetic macrocycles containing amino acid sequences with at least two modified amino acids that form an intramolecular cross-link that can help to stabilize a secondary structure of the amino acid sequence. Suitable sequences for stabilization include those with homology to the p53 protein. These sequences can bind to the MDM2 and/or MDMX proteins. Also provided herein are methods of using such macrocycles for the treatment of diseases and disorders, such as cancers or other disorders characterized by a low level or low activity of a p53 protein or high level of activity of a MDM2 and/or MDMX protein.Type: GrantFiled: December 18, 2018Date of Patent: April 6, 2021Assignee: AILERON THERAPEUTICS, INC.Inventors: Vincent Guerlavais, Carl Elkin, Huw M. Nash, Tomi K. Sawyer, Bradford J. Graves, Eric Feyfant
-
Patent number: 10902660Abstract: Aspects of the disclosure relate to a method for providing an animated presentation. The method includes identifying a geographic area and identifying solar flux for the geographic area. A plurality of images of the geographic area then is generated to display the solar flux. Each image in the plurality of images displays solar flux at different points in time of a day. The animated presentation is generated by displaying the plurality of images in chronological order with a transition between images in the plurality of images and provided for display on a display to a user.Type: GrantFiled: March 14, 2019Date of Patent: January 26, 2021Assignee: Google LLCInventors: David Kogan, Carl Elkin, Warren Wang, Carlos David Correa Ocampo
-
Publication number: 20190343914Abstract: Provided herein are peptidomimetic macrocycles containing amino acid sequences with at least two modified amino acids that form an intramolecular cross-link that can help to stabilize a secondary structure of the amino acid sequence. Suitable sequences for stabilization include those with homology to the p53 protein. These sequences can bind to the MDM2 and/or MDMX proteins. Also provided herein are methods of using such macrocycles for the treatment of diseases and disorders, such as cancers or other disorders characterized by a low level or low activity of a p53 protein or high level of activity of a MDM2 and/or MDMX protein.Type: ApplicationFiled: December 18, 2018Publication date: November 14, 2019Inventors: Vincent GUERLAVAIS, Carl ELKIN, Huw M. NASH, Tomi K. SAWYER, Bradford J. GRAVES, Eric FEYFANT
-
Publication number: 20190225650Abstract: The present invention provides peptidomimetic macrocycles capable of regulating HIF1? and methods of using such macrocycles for the treatment of diseases.Type: ApplicationFiled: January 30, 2019Publication date: July 25, 2019Inventors: Vincent GUERLAVAIS, Noriyuki KAWAHATA, Huw M. NASH, Carl ELKIN, Eric FEYFANT
-
Publication number: 20190221023Abstract: Aspects of the disclosure relate to a method for providing an animated presentation. The method includes identifying a geographic area and identifying solar flux for the geographic area. A plurality of images of the geographic area then is generated to display the solar flux. Each image in the plurality of images displays solar flux at different points in time of a day. The animated presentation is generated by displaying the plurality of images in chronological order with a transition between images in the plurality of images and provided for display on a display to a user.Type: ApplicationFiled: March 14, 2019Publication date: July 18, 2019Applicant: Google LLCInventors: David Kogan, Carl Elkin, Warren Wang, Carlos David Correa Ocampo
-
Patent number: 10275923Abstract: Aspects of the disclosure relate to a method for providing an animated presentation. The method includes identifying a geographic area and identifying solar flux for the geographic area. A plurality of images of the geographic area then is generated to display the solar flux. Each image in the plurality of images displays solar flux at different points in time of a day. The animated presentation is generated by displaying the plurality of images in chronological order with a transition between images in the plurality of images and provided for display on a display to a user.Type: GrantFiled: February 9, 2016Date of Patent: April 30, 2019Assignee: Google LLCInventors: David Kogan, Carl Elkin, Warren Wang, Carlos David Correa Ocampo
-
Patent number: 10246491Abstract: The present invention provides peptidomimetic macrocycles capable of regulating HIF1? and methods of using such macrocycles for the treatment of diseases.Type: GrantFiled: September 2, 2015Date of Patent: April 2, 2019Assignee: AILERON THERAPEUTICS, INC.Inventors: Vincent Guerlavais, Noriyuki Kawahata, Huw M. Nash, Carl Elkin, Eric Feyfant
-
Patent number: 10213477Abstract: Provided herein are peptidomimetic macrocycles containing amino acid sequences with at least two modified amino acids that form an intramolecular cross-link that can help to stabilize a secondary structure of the amino acid sequence. Suitable sequences for stabilization include those with homology to the p53 protein. These sequences can bind to the MDM2 and/or MDMX proteins. Also provided herein are methods of using such macrocycles for the treatment of diseases and disorders, such as cancers or other disorders characterized by a low level or low activity of a p53 protein or high level of activity of a MDM2 and/or MDMX protein.Type: GrantFiled: August 5, 2016Date of Patent: February 26, 2019Assignee: Aileron Therapeutics, Inc.Inventors: Vincent Guerlavais, Carl Elkin, Huw M. Nash, Tomi K. Sawyer, Bradford J. Graves, Eric Feyfant
-
Publication number: 20170281720Abstract: Provided herein are peptidomimetic macrocycles containing amino acid sequences with at least two modified amino acids that form an intramolecular cross-link that can help to stabilize a secondary structure of the amino acid sequence. Suitable sequences for stabilization include those with homology to the p53 protein. These sequences can bind to the MDM2 and/or MDMX proteins. Also provided herein are methods of using such macrocycles for the treatment of diseases and disorders, such as cancers or other disorders characterized by a low level or low activity of a p53 protein or high level of activity of a MDM2 and/or MDMX protein.Type: ApplicationFiled: August 5, 2016Publication date: October 5, 2017Inventors: Vincent GUERLAVAIS, Carl ELKIN, Huw M. NASH, Tomi K. SAWYER, Bradford J. GRAVES, Eric FEYFANT
-
Publication number: 20170228913Abstract: Aspects of the disclosure relate to a method for providing an animated presentation. The method includes identifying a geographic area and identifying solar flux for the geographic area. A plurality of images of the geographic area then is generated to display the solar flux. Each image in the plurality of images displays solar flux at different points in time of a day. The animated presentation is generated by displaying the plurality of images in chronological order with a transition between images in the plurality of images and provided for display on a display to a user.Type: ApplicationFiled: February 9, 2016Publication date: August 10, 2017Inventors: David Kogan, Carl Elkin, Warren Wang, Carlos David Correa Ocampo
-
Patent number: 9505804Abstract: Provided herein are peptidomimetic macrocycles containing amino acid sequences with at least two modified amino acids that form an intramolecular cross-link that can help to stabilize a secondary structure of the amino acid sequence. Suitable sequences for stabilization include those with homology to the p53 protein. These sequences can bind to the MDM2 and/or MDMX proteins. Also provided herein are methods of using such macrocycles for the treatment of diseases and disorders, such as cancers or other disorders characterized by a low level or low activity of a p53 protein or high level of activity of a MDM2 and/or MDMX protein.Type: GrantFiled: September 26, 2014Date of Patent: November 29, 2016Assignee: AILERON THERAPEUTICS, INC.Inventors: Vincent Guerlavais, Carl Elkin, Huw M. Nash, Tomi K. Sawyer, Bradford J. Graves, Eric Feyfant
-
Publication number: 20160052970Abstract: The present invention provides peptidomimetic macrocycles capable of regulating HIF1? and methods of using such macrocycles for the treatment of diseases.Type: ApplicationFiled: September 2, 2015Publication date: February 25, 2016Inventors: Vincent GUERLAVAIS, Noriyuki KAWAHATA, Huw M. NASH, Carl ELKIN, Eric FEYFANT
-
Publication number: 20150051155Abstract: Provided herein are peptidomimetic macrocycles containing amino acid sequences with at least two modified amino acids that form an intramolecular cross-link that can help to stabilize a secondary structure of the amino acid sequence. Suitable sequences for stabilization include those with homology to the p53 protein. These sequences can bind to the MDM2 and/or MDMX proteins. Also provided herein are methods of using such macrocycles for the treatment of diseases and disorders, such as cancers or other disorders characterized by a low level or low activity of a p53 protein or high level of activity of a MDM2 and/or MDMX protein.Type: ApplicationFiled: September 26, 2014Publication date: February 19, 2015Inventors: Vincent GUERLAVAIS, Carl ELKIN, Huw M. NASH, Tomi K. SAWYER, Bradford J. GRAVES, Eric FEYFANT
-
Patent number: 8927500Abstract: Provided herein are peptidomimetic macrocycles containing amino acid sequences with at least two modified amino acids that form an intramolecular cross-link that can help to stabilize a secondary structure of the amino acid sequence. Suitable sequences for stabilization include those with homology to the p53 protein. These sequences can bind to the MDM2 and/or MDMX proteins. Also provided herein are methods of using such macrocycles for the treatment of diseases and disorders, such as cancers or other disorders characterized by a low level or low activity of a p53 protein or high level of activity of a MDM2 and/or MDMX protein.Type: GrantFiled: February 14, 2013Date of Patent: January 6, 2015Assignee: Aileron Therapeutics, Inc.Inventors: Vincent Guerlavais, Carl Elkin, Huw M. Nash, Tomi K. Sawyer, Bradford J. Graves, Eric Feyfant
-
Publication number: 20130274205Abstract: Provided herein are peptidomimetic macrocycles and methods of using such macrocycles for the treatment of disease.Type: ApplicationFiled: February 14, 2013Publication date: October 17, 2013Inventors: Vincent Guerlavais, Carl Elkin, Huw M. Nash, Tomi K. Sawyer, Bradford J. Graves, Eric Feyfant
-
Publication number: 20100298164Abstract: A method for the structure-based identification and selection of inhibitors of processivity factor binding to protein is disclosed herein. Characterization of the protein/processivity factor interface is given. Methods for the structure-based inhibition of processivity factor binding to protein are also given. One embodiment includes a class of peptidomimetics that mimic helical portions of proteins. In addition, methods of treatment of various diseases are given, using the inhibitors of the invention.Type: ApplicationFiled: July 2, 2010Publication date: November 25, 2010Inventors: Donald Coen, James Hogle, Carl Elkin, Harmon J. Zuccola, Kristie Grove Bridges, Scott Lokey
-
Patent number: 7388070Abstract: A method for the structure-based identification and selection of inhibitors of processivity factor binding to protein is disclosed herein. Characterization of the protein/processivity factor interface is given. Methods for the structure-based inhibition of processivity factor binding to protein are also given. One embodiment includes a class of peptidomimetics that mimic helical portions of proteins. In addition, methods of treatment of various diseases are given, using the inhibitors of the invention.Type: GrantFiled: May 12, 2000Date of Patent: June 17, 2008Assignee: President and Fellows of Harvard CollegeInventors: Donald Coen, James Hogle, Carl Elkin, Harmon J. Zuccola, Kristie Grove Bridges, Scott Lokey
-
Publication number: 20070055459Abstract: A method for the structure-based identification and selection of inhibitors of processivity factor binding to protein is disclosed herein. Characterization of the protein/processivity factor interface is given. Methods for the structure-based inhibition of processivity factor binding to protein are also given. One embodiment includes a class of peptidomimetics that mimic helical portions of proteins. In addition, methods of treatment of various diseases are given, using the inhibitors of the invention.Type: ApplicationFiled: November 6, 2006Publication date: March 8, 2007Inventors: Donald Coen, James Hogle, Carl Elkin, Harmon Zuccola, Kristie Bridges, Scott Lokey